A Multicenter retrospective study on hypersensitivity reactions to Non-Steroidal Anti-inflammatory Drugs (NSAIDs) in children: a report from the European Network on Drug Allergy (ENDA) group.
Diagnosis of hypersensitivity (HS) reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children is complex. The real prevalence of NSAIDs HS remains unknown because a drug provocation test (DPT) is not always performed with the culprit NSAID. To describe and compare the diagnostic workup among different European centers and to find out the real proportion of NSAIDs HS by performing a DPT with the culprit drug. We retrospectively collected data from children (0-10 years) and adolescents (10-18 years) with a history of NSAIDs reactions and who underwent a complete allergy workup including DPTs with the culprit in six different pediatric centers: Belgrade, Florence, Geneva, Madrid, Porto, and Rome. A total of 693 children with a history of NSAIDs reactions were enrolled and a total of 526 DPTs were performed with the culprit NSAID. The diagnosis of NSAIDs HS was confirmed in (103/526) 19.6% of children by performing a DPT with the culprit drug. The major differences in the allergy workup among the six centers concerned the duration of the DPT and the practical use of skin tests for diagnosing NSAIDs HS. In addition, the use of acetyl salicylic acid (ASA) to differentiate single reactors (SR) or cross-intolerance (CI) patients is not commonly used except in Spain. The value of this study is that although different approaches are used around Europe to diagnose NSAIDs HS, we found that the percentage of confirmed NSAIDs HS is less than 20%. This highlights the importance of the DPT in confirming or excluding NSAIDs HS in the pediatric population.